Yahoo

C.H. Robinson Worldwide (CHRW) Stock Fair Value Edges Lower As Analysts Trim Targets

Explore stocks on Coinbase

C.H. Robinson Worldwide is seeing a modest reset in expectations, with a fair value estimate easing from US$194.57 to US$182.78. This shift lines up with recent Street research that trims price targets while still reflecting generally constructive views on execution and long term earnings power, especially around the RXO acquisition and Lean AI rollout. In the sections that follow, you will see how these changing targets fit into the broader narrative and how to keep track of the story as it develops.

Stay updated as the Fair Value for C.H. Robinson Worldwide shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on C.H. Robinson Worldwide.

What Wall Street Has Been Saying

🐂 Bullish Takeaways

  • Several firms, including JPMorgan, Citi, Truist, Evercore ISI, BofA, Raymond James, Stephens, Baird and Freedom Broker, keep positive ratings on C.H. Robinson Worldwide even as they reset price targets. This signals continued confidence in execution and long term earnings power.

  • BofA and Wells Fargo see the RXO acquisition as financially credible, with BofA pointing to a track record of productivity and Wells Fargo describing the transaction thesis as compelling with material value creation potential.

  • Truist, Raymond James and JPMorgan highlight improving truckload and contract rate fundamentals and the potential for earnings leverage as market conditions and pricing frameworks evolve.

  • Citi and Freedom Broker frame current valuation and operating performance as supportive for a constructive view, with Citi describing current share levels as an opportunity to buy quality at a reasonable price.

🐻 Bearish Takeaways

  • Deutsche Bank cut its rating to Hold and lowered its target to US$153, citing higher leverage from the RXO acquisition and a steep synergy ramp that could take time to validate.

  • BMO Capital and Bernstein keep more neutral ratings, flagging factors such as insurance cost pressure on brokers like C.H. Robinson and the view that RXO accretion, while credible, is not yet enough to justify a more constructive stance.

Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives!

NasdaqGS:CHRW 1-Year Stock Price Chart
NasdaqGS:CHRW 1-Year Stock Price Chart

We've flagged 1 risk for C.H. Robinson Worldwide. See which could impact your investment.

How This Changes the Fair Value For C.H. Robinson Worldwide

  • The Fair Value Estimate for C.H. Robinson Worldwide has moved from US$194.57 to US$182.78.

  • The revenue growth assumption has adjusted from about 6.20% to about 4.09%.

  • The net profit margin assumption has moved from about 4.69% to about 4.68%.

  • The future P/E multiple has shifted from about 29.1x to about 27.7x.

  • The discount rate has changed from 8.01% to about 8.07%.

Never Miss an Update: Follow The Narrative

Narratives link C.H. Robinson Worldwide's business story to a financial forecast and fair value that update as new information comes in. They help you see how catalysts and risks connect to the numbers analysts are using.

Head over to the Simply Wall St Community and follow the Narrative on C.H. Robinson Worldwide to stay up to date on:

  • How Lean AI, automation and a large data set are being applied across NAST, Global Forwarding and LTL to target higher productivity and operating margins.

  • Whether industry consolidation and shipper preference for larger, well insured providers translate into durable market share gains and revenue growth for C.H. Robinson Worldwide.

  • How legal and insurance risks, including exposure to large jury awards and any shift in broker liability, could affect margins, earnings and the broader investment case.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include CHRW .

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Mobilize your Website
View Site in Mobile | Classic
Share by: